Literature DB >> 18234058

Up-regulation of the phosphoinositide 3-kinase pathway in human lamina propria T lymphocytes.

J Braunstein1, F Autschbach, T Giese, F Lasitschka, A Heidtmann, B Sido, B Funke, C Reiser, A J Schröder, G Nebl, Y Samstag, S C Meuer.   

Abstract

Human intestinal lamina propria T lymphocytes (LPT), when investigated ex vivo, exhibit functional properties profoundly different from those of peripheral blood T lymphocytes (PBT). One prominent feature represents their enhanced sensitivity to CD2 stimulation when compared to PBT. Given that LPT are hyporesponsive to T cell receptor (TCR)/CD3 stimulation, an alternative activation mode, as mimicked by CD2 triggering in vitro, may be functional in mucosal inflammation in vivo. This study provides insight into signalling events associated with the high CD2 responsiveness of LPT. When compared to PBT, LPT show an increased activation of the phosphoinositide 3/protein kinase B/glycogen synthase kinase 3beta (PI3-kinase/AKT/GSK-3beta) pathway in response to CD2 stimulation. Evidence is provided that up-regulation of this pathway contributes to the enhanced CD2-induced cytokine production in LPT. Given the importance of TCR-independent stimulation for the initiation of intestinal immune responses analysis of signalling pathways induced by 'co-stimulatory' receptors may provide valuable information for therapeutic drug design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234058      PMCID: PMC2276955          DOI: 10.1111/j.1365-2249.2007.03562.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  Isolation and phenotypic characterization of colonic macrophages.

Authors:  G Rogler; M Hausmann; D Vogl; E Aschenbrenner; T Andus; W Falk; R Andreesen; J Schölmerich; V Gross
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

2.  T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1.

Authors:  C Loh; J A Carew; J Kim; P G Hogan; A Rao
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  T cells of the human intestinal lamina propria are high producers of interleukin-10.

Authors:  J Braunstein; L Qiao; F Autschbach; G Schürmann; S Meuer
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

4.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

5.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

6.  Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.

Authors:  P Brennan; J W Babbage; B M Burgering; B Groner; K Reif; D A Cantrell
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

7.  Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3.

Authors:  C R Beals; C M Sheridan; C W Turck; P Gardner; G R Crabtree
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

8.  Hypoproliferative human lamina propria T cells retain the capacity to secrete lymphokines when stimulated via CD2/CD28 pathways.

Authors:  M Boirivant; I Fuss; C Fiocchi; J S Klein; S A Strong; W Strober
Journal:  Proc Assoc Am Physicians       Date:  1996-01

9.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.

Authors:  D A Cross; D R Alessi; P Cohen; M Andjelkovich; B A Hemmings
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

10.  In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease.

Authors:  F Autschbach; J Braunstein; B Helmke; I Zuna; G Schürmann; Z I Niemir; R Wallich; H F Otto; S C Meuer
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  6 in total

1.  Human mucosal CD4+ T cells but not blood CD4+ T cells respond vigorously towards CD28 engagement.

Authors:  J Schröder-Braunstein; V Pavlov; T Giese; A Heidtmann; S Wentrup; F Lasitschka; J Winter; A Ulrich; A Engelke; M Al Saeedi; S Meuer
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

2.  HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms.

Authors:  Delphine Planas; Yuwei Zhang; Patricia Monteiro; Jean-Philippe Goulet; Annie Gosselin; Nathalie Grandvaux; Thomas J Hope; Ariberto Fassati; Jean-Pierre Routy; Petronela Ancuta
Journal:  JCI Insight       Date:  2017-08-03

3.  TGF-β conditions intestinal T cells to express increased levels of miR-155, associated with down-regulation of IL-2 and itk mRNA.

Authors:  L M Das; M D L A Torres-Castillo; T Gill; A D Levine
Journal:  Mucosal Immunol       Date:  2012-07-11       Impact factor: 7.313

4.  Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®.

Authors:  Anne-Kristin Heninger; Sabine Wentrup; Mohammed Al-Saeedi; Serin Schiessling; Thomas Giese; Florian Wartha; Stefan Meuer; Jutta Schröder-Braunstein
Journal:  Immun Inflamm Dis       Date:  2014-11-03

5.  Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate.

Authors:  Felix Lasitschka; Thomas Giese; Marco Paparella; Stefan R Kurzhals; Guido Wabnitz; Katrin Jacob; Judith Gras; Konrad A Bode; Anne-Kristin Heninger; Timea Sziskzai; Yvonne Samstag; Cornelia Leszinski; Bettina Jocher; Mohammed Al-Saeedi; Stefan C Meuer; Jutta Schröder-Braunstein
Journal:  Immun Inflamm Dis       Date:  2017-07-06

6.  The role of phosphoinositide 3-kinase signaling in intestinal inflammation.

Authors:  Catherine M Cahill; Jack T Rogers; W Allan Walker
Journal:  J Signal Transduct       Date:  2012-04-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.